Transitioning from medicine to industry: general considerations
Heart Podcast
00:00
Biotech Startups - Are You Planning to Stay in the UK?
Ampaglophos was preclinical and still maybe years away from clinic. The further away you are from clinic, the more risk you're taking. Although, in my case, risk has beaten reward at the moment. But yeah, as you say, can we ask about your plan? Are you planning to stay within biotech?"
Transcript
Play full episode
